These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23417514)

  • 1. An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.
    Fox MA; Panessiti MG; Hall FS; Uhl GR; Murphy DL
    Psychopharmacology (Berl); 2013 Jun; 227(4):685-95. PubMed ID: 23417514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
    Uchiumi O; Kasahara Y; Fukui A; Hall FS; Uhl GR; Sora I
    Neuropharmacology; 2013 Jan; 64():348-56. PubMed ID: 22809709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.
    Saunders C; Siuta M; Robertson SD; Davis AR; Sauer J; Matthies HJG; Gresch PJ; Airey D; Lindsley CW; Schetz JA; Niswender KD; Veenstra-Vanderweele JM; Galli A
    Neurochem Int; 2014 Jul; 73():113-121. PubMed ID: 24090638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
    Fox MA; Stein AR; French HT; Murphy DL
    Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.
    Shanahan NA; Holick Pierz KA; Masten VL; Waeber C; Ansorge M; Gingrich JA; Geyer MA; Hen R; Dulawa SC
    Biol Psychiatry; 2009 Mar; 65(5):401-8. PubMed ID: 19013555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT
    Hagino Y; Hall FS; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacol Rep; 2021 Mar; 41(1):91-101. PubMed ID: 33547882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT
    Nikolaus S; Chao OY; Beu M; Henke J; Antke C; Wang AL; Fazari B; Mamlins E; Huston JP; Giesel FL
    Neurobiol Learn Mem; 2023 Nov; 205():107848. PubMed ID: 37865262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats.
    Gaggi R; Dall'Olio R; Roncada P
    Gen Pharmacol; 1997 Apr; 28(4):583-7. PubMed ID: 9147028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferulic acid alleviates abnormal behaviors in isolation-reared mice via 5-HT
    Araki R; Yasubuchi A; Ikegaya M; Hojo C; Tachioka H; Kawai K; Omote M; Kita A; Yabe T
    Psychopharmacology (Berl); 2021 Aug; 238(8):2147-2154. PubMed ID: 33829309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT
    Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
    Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
    Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
    Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
    Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.
    Mato S; Aso E; Castro E; Martín M; Valverde O; Maldonado R; Pazos A
    J Neurochem; 2007 Dec; 103(5):2111-20. PubMed ID: 17944876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N; Friedman E
    Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
    Zhang Y; Gray TS; D'Souza DN; Carrasco GA; Damjanoska KJ; Dudas B; Garcia F; Zainelli GM; Sullivan Hanley NR; Battaglia G; Muma NA; Van de Kar LD
    J Pharmacol Exp Ther; 2004 Jul; 310(1):59-66. PubMed ID: 15064330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system.
    Adinolfi A; Zelli S; Leo D; Carbone C; Mus L; Illiano P; Alleva E; Gainetdinov RR; Adriani W
    Behav Brain Res; 2019 Feb; 359():516-527. PubMed ID: 30472113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.